Curriculum Vitaes
Profile Information
- Affiliation
- School of Medicine Faculty of Medicine, Fujita Health University理事長, 一般社団法人 SSCI-Net
- Degree
- 医学博士(藤田保健衛生大学)
- J-GLOBAL ID
- 200901019418727145
- researchmap Member ID
- 1000102542
2000年5月から藤田保健衛生大学医学部皮膚科学講座教授としてあらゆる皮膚疾患に対応できる診療,教育,研究をおこなってきましたが,その中で,皮膚アレルギー,接触皮膚炎,皮膚安全性研究,食物アレルギーなどを専門領域にしてまいりました.2016年藤田保健衛生大学医学部アレルギー疾患対策医療学講座教授として大学に残り,さらにアレルギー疾患の患者さんの治療とQOL向上のために役立つ研究を総合的にすすめております.
Research Interests
5Research Areas
2Research History
13-
Apr, 2014 - Mar, 2016
-
2013 - Mar, 2015
-
2012 - 2013
Education
1-
- Mar, 1976
Committee Memberships
95-
Jul, 2016 - Present
-
Apr, 2015 - Present
-
May, 2013 - Present
-
Jan, 2013 - Present
-
Jul, 2014 - 2017
Awards
8-
May, 2020
-
2017
-
2016
-
2015
-
2014
Papers
584-
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 37(2) e70291, Feb, 2026BACKGROUND: Despite the increasing prevalence of walnut allergy (WA), no allergen components have been established as markers of disease severity. This study aimed to identify proteins specifically associated with severe WA in children. METHODS: We analyzed 48 children aged 3.4-16 years who underwent an oral food challenge to walnut between February 2019 and March 2022. Children with positive and negative reactions were categorized into a WA group and walnut sensitization (WS) group, respectively. The dose-adjusted reaction severity of WA patients was quantified using the Anaphylaxis Scoring Aichi's total score divided by the cumulative protein dose that induced symptoms (TS/Pro). Using the median TS/Pro value in all cases of the WA group as a cut-off, 11 of 21 WA patients with stored sera were classified as high TS/Pro (TS/Pro ≥154.1); the remaining 10 patients were classified as low TS/Pro. Immunoblotting, mass spectrometry, and enzyme-linked immunosorbent assay (ELISA) were used to identify candidate markers of WA severity. RESULTS: Jug r 1-specific IgE (sIgE) levels were higher in the WA group, but were not significantly associated with TS/Pro. Immunoblotting and mass spectrometry detected phospholipase D alpha 1 (PLDa1) in 5/11 (45.5%) high TS/Pro patients and 1/10 (10%) low TS/Pro patients (p = .149). ELISA with recombinant PLDa1 confirmed similar results. Moreover, the absorbance of recombinant PLDa1-sIgE was significantly correlated with TS/Pro (ρ = 0.47, p = .032). CONCLUSIONS: PLDa1 (Jug r 9) is a candidate marker of WA severity. The early identification of children at risk of severe WA may aid clinicians in optimizing their management strategies.
-
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 36(12) e70254, Dec, 2025BACKGROUND: The relationship between the severity of peanut allergy and component-specific immunoglobulin E (IgE) remains partially analyzed. We aimed to explore this relationship using a proteomic analysis of pediatric patients with peanut allergy. METHODS: Immunoblotting and mass spectrometry were used to identify candidate peanut allergen components, which were confirmed via enzyme-linked immunosorbent assay using sera from pediatric patients with peanut allergy confirmed through a positive oral food challenge test (OFC). The association between each protein-specific IgE level and the severity of peanut allergy was compared. The severity of peanut allergy was quantified as TS/Pro, which is the total score (TS) of Anaphylaxis Scoring Aichi divided by the cumulative protein dose of peanuts at the OFC (Pro). RESULTS: This study comprised 52 patients with peanut allergy. In addition to the known peanut allergen components, we discovered seven allergens in more than five participants. Among the participants, 24 (46.2%) had Annexin Gh1-specific IgE. Ara h 2 (rs = 0.67, p < .001) and Ara h 6 (rs = 0.66, p < .001) specific IgEs and the sum of the absorbance of all seven candidates (rs = 0.64, p < .001) were strongly correlated with TS/Pro. Ara h 1 (rs = 0.30, p < .05), Ara h 3 (rs = 0.37, p < .01), Ara h 7 (rs = 0.34, p < .05), and the seed biotin-containing protein SBP65 (rs = 0.35, p < .05) specific IgEs were correlated with TS/Pro. CONCLUSION: Ara h 2- and 6-specific IgEs and sensitization diversity were the most significant factors that correlated with peanut allergy severity. We identified SBP65 (Ara h 20) as a potential novel allergen component related to peanut allergy severity.
-
Allergology international : official journal of the Japanese Society of Allergology, 74(3) 485-487, Jul, 2025
-
The Journal of dermatology, 52(5) 888-896, May, 2025Patients with peach allergy who experience severe symptoms, including anaphylaxis, reportedly have a higher positivity for peach gibberellin-regulated protein (GRP)-specific immunoglobulin (Ig) E than those with only oral symptoms. However, a study in Italy investigating apple allergy (another Rosaceae fruit) found no clear association between apple GRP-specific IgE levels and clinical disease types. This study aimed to evaluate the clinical utility of GRP-specific IgE measurement in Japanese patients with apple allergy. We collected sera from apple-allergic patients in Japan and measured their IgE levels specific to apple GRP. Apple-allergic patients (14 with oral reactions and 14 with systemic reactions) and seven non-allergic controls were examined. The specific IgE levels against apple, Mal d 1, Mal d 4, Japanese cedar, Japanese alder, Japanese white birch, Bet v 1, and Bet v 2 were also determined using 3gAllergy™. Positive results for apple-GRP-specific IgE by enzyme-linked immunosorbent assay were obtained in one patient with oral reactions and in seven cases of systemic reactions. Exercise as a cofactor was involved in cases with high apple GRP-specific IgE. GRP expression was considerably lower in apples than in peaches, as detected by reverse transcription-quantitative polymerase chain reaction testing. Thus, GRP-specific IgE may be an important marker for diagnosing systemic reactions triggered by exercise in fruits with low GRP expression, such as apples.
Misc.
1280-
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 123(2) S38-S38, Feb, 2009
-
LASERS IN SURGERY AND MEDICINE, 100-100, 2009
-
LASERS IN SURGERY AND MEDICINE, 36-36, 2009
-
Allergology International, 58(3) 347-355, 2009
-
Journal of Environmental Dermatology and Cutaneous Allergology, 3(4) 243-243, 2009
-
Journal of Environmental Dermatology and Cutaneous Allergology, 3(4) 371-371, 2009
-
Journal of Environmental Dermatology and Cutaneous Allergology, 3(1) 32-41, Jan, 2009
-
Journal of Environmental Dermatology and Cutaneous Allergology, 3(2) 94-100, 2009
-
Journal of Environmental Dermatology and Cutaneous Allergology, 3(2) 105-110, 2009
-
The Japanese Journal of Dermatology, 119(9) 1795-1809, 2009[Purpose] To clarify incidence and difference of gender and age in skin disorders of dermatological patients in the early 21st century in Japan. [Methods] Nationwide cross-sectional and seasonal multicenter study was conducted by 76 university hospitals, 55 district-based pivotal hospitals and 59 private clinics (190 clinics in total). In each clinic, information on diagnosis, age and gender was collected from all of the out-patients and in-patients visited on any one day of the second week of May, August and November 2007 and February 2008. Average high and low monthly temperature and humidity reports were collected from the Meteorological Agency. [Results] The information on 67,448 cases from 170 clinics (69 university hospitals, 45 district-based pivotal hospitals and 56 private clinics) participated in all of the 4 seasonal examination, was analyzed. Top 20 skin disorders were, in high incidence order, miscellaneous eczema, atopic dermatitis, tinea pedis, urticarial/angioedema, tinea unguium, viral warts, psoriasis, contact dermatitis, acne, seborrheic dermatitis, hand eczema, miscellaneous benign skin tumors, alopecia areata, herpes zoster/postherpetic neuralgia, skin ulcers (nondiabetic), prurigo, epidermoid cysts, vitiligo vulgaris, sebborheic keratosis, and drug eruption/toxicoderma. The vast majority (85.34%) of dermatological patients were covered under the top 20 disorders. Each disorder showed its own specific age distribution. The number of patients was correlated with average high and low monthly temperature in disorders such as atopic dermatitis, contact dermatitis, urticarial/angioedema, prurigo, insect bites and tinea pedis. Male-prone (psoriasis, erythroderma, diabetic dermatoses, e. t. c.) and female prone (erythema nodosum, collagen diseases, livedo reticularis/racemosa, hand eczema, e. t. c.) diseases were clearly evident. [Conclusion] This study apparently highlights the present situation of dermatological patients in the early 21st century of Japan. It is necessary to continue to perform the similar study periodically from social dermatological point of view.
-
MEDICAL MYCOLOGY, 47(6) 618-624, 2009
-
JOURNAL OF DERMATOLOGY, 36(1) 45-49, Jan, 2009
-
JOURNAL OF DERMATOLOGY, 36(1) 50-55, Jan, 2009
-
CONTACT DERMATITIS, 60(3) 183-184, 2009
-
Allergology International, 58(3) 347-355, 2009
-
JOURNAL OF COSMETIC AND LASER THERAPY, 11(4) 216-219, 2009
-
Cardiovascular Revascularization Medicine, 10(1) 17-22, Jan, 2009
-
PHARMACOGENOMICS, 9(11) 1617-1622, Nov, 2008
-
Hifu no kagaku, 7(4) 460-465, Aug, 2008A 71-year-old male had suffered from painful dark red nodules on his right leg for three months. He had chronic hypersensitivity pneumonitis treated with prednisolone(10mg/day) and diabetes mellitus caused by steroids. He sometimes cultivated the land on the hill for fun. Culture of a skin biopsy specimen from the nodule yielded white colonies after five days, and DNA -DNA hybridization revealed that these were Mycobacterium chelonae. The patient was treated with levofloxacin 300mg/day and clarithromycin 400mg/day, which successfully improved his conditions. Recently, clarithromycin has become recognized as an effective agent in the treatment of cutaneous M. chelonae, and it was also effective in our case. Further discussions are needed to decide when to stop medication without recurrence.
Books and Other Publications
62-
Kyowa Kikaku, Jul, 2016 (ISBN: 9784877941826)
Presentations
596-
The 8th International Rubber Glove Conference and Exhibition, Sep 6, 2016 Invited
-
The 40th Annual Meeting of The Japanese Society of The Pediatric Dermatology, Jul 3, 2016
Professional Memberships
21Research Projects
7-
科学研究費助成事業, 日本学術振興会, Apr, 2021 - Mar, 2024
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2017 - Mar, 2020
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2013 - Mar, 2017
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2012 - Mar, 2015
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, 2010 - 2012
Social Activities
57Media Coverage
38作成した教科書、教材、参考書
5-
件名(英語)蕁麻疹・血管性浮腫 パーフェクトマスター皮膚科臨床アセット16終了年月日(英語)2013概要(英語)最新のガイドラインに基づき、蕁麻疹を深く掘り下げて解説した。
-
件名(英語)油脂・脂質・界面活性剤データブック終了年月日(英語)2012概要(英語)化学の全体像を提示することを主な目的としている“便覧”に記述されている基礎的データを生かしながら,現場に役に立つ最新のデータを加味したデータブックをまとめた。
-
件名(英語)藤田保健衛生大学病院における卒後臨床研修への取り組み終了年月日(英語)2012概要(英語)必修化新臨床研修制度が平成16年4月に導入されて8年が経過した. 新医師臨床研修制度の基本理念を実現するために, この9年間に卒後臨床研修の改善と充実, 屋根瓦方式による指導体制の確立に向けて 臨床研修センター(センター)が中心に行ってきた様々な取り組みについて示した。
-
件名(英語)日本美容皮膚科学会用語集終了年月日(英語)2011概要(英語)美容皮膚科学を習得する際に必要な用語を選定した。
-
件名(英語)アトピー性皮膚炎-湿疹・皮膚炎パーフェクトマスター 皮膚科臨床アセット1終了年月日(英語)2011概要(英語)日本皮膚科学会作成の診療ガイドラインを基に、薬物治療・スキンケア・悪化因子の除去などについて詳述した。
教育方法・教育実践に関する発表、講演等
3-
件名(英語)CBT試験問題作成・ブラッシュアップワークショップ終了年月日(英語)2013概要(英語)第46回藤田保健衛生大学医学部医学教育ワークショップに参加しCBTのブラッシュアップを行った。
-
件名(英語)理容・美容における化粧品の皮膚への影響とその取扱い終了年月日(英語)2012概要(英語)理容・美容師向けの保健研修カリキュラムの一環として講義を行った。
-
件名(英語)理容・美容における化粧品の皮膚への影響とその取扱い終了年月日(英語)2011概要(英語)理容・美容師向けの保健研修カリキュラムの一環として講義を行った。
その他教育活動上特記すべき事項
16-
件名(英語)医学部M4〜M6担任開始年月日(英語)2011終了年月日(英語)2013
-
件名(英語)大学院医学研究科委員会委員開始年月日(英語)2010終了年月日(英語)2012
-
件名(英語)教務・学生指導合同委員会委員開始年月日(英語)2010終了年月日(英語)2013
-
件名(英語)茶道部部長開始年月日(英語)2009終了年月日(英語)2013
-
件名(英語)卒後医学教育委員会委員開始年月日(英語)2010終了年月日(英語)2013
-
件名(英語)私立医科大学協会委員会委員終了年月日(英語)2011
-
件名(英語)環境保全委員会副委員長終了年月日(英語)2011
-
件名(英語)入試委員会委員開始年月日(英語)2010終了年月日(英語)2011
-
件名(英語)CM-E国内委員会委員終了年月日(英語)2010
-
件名(英語)医学部MOU国際交流委員会委員終了年月日(英語)2010
-
件名(英語)後期研修委員会委員終了年月日(英語)2010
-
件名(英語)学事協議会構成員終了年月日(英語)2010
-
件名(英語)薬事委員会開始年月日(英語)2009終了年月日(英語)2012
-
件名(英語)褥瘡対策実務委員会開始年月日(英語)2009終了年月日(英語)2012
-
件名(英語)副院長開始年月日(英語)2009終了年月日(英語)2012
-
件名(英語)臨床研修センター長開始年月日(英語)2009終了年月日(英語)2012